Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens

PloS One
Aparna VasanthakumarMartin Lagging

Abstract

Genetic variants of inosine triphosphatase (ITPA) that confer reduced ITPase activity are associated with protection against ribavirin(RBV)-induced hemolytic anemia in peginterferon(IFN)/RBV-based treatment of hepatitis C virus (HCV). Patients with reduced ITPase activity showed improved treatment efficacy when treated with IFN/RBV. In addition, a genetic polymorphism near the IL28B gene is associated with an improved response to IFN/RBV treatment. RBV has been an important component of IFN-containing regimens, and is currently recommended in combination with several IFN-free regimens for treatment of harder to cure HCV infections. To evaluate whether genetic variations that reduce ITPase activity impact RBV-induced anemia in IFN-free/RBV regimens. In this study, genetic analyses were conducted in the PEARL-IV trial to investigate the effect of activity-reducing ITPA variants as well as IL28B polymorphism on anemia, platelet (PLT) counts, and virologic response in HCV genotype1a-infected patients treated with the direct-acting antiviral (DAA) regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir±RBV. Reduction in ITPase activity and homozygosity for the IL28Brs12979860 CC genotype protected against RBV-induced anemia. In p...Continue Reading

References

Jan 1, 1990·The International Journal of Biochemistry·T Page, J D Connor
Mar 25, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L De FranceschiR Corrocher
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Oct 18, 2002·Human Genetics·Satoshi SumiJohn A Duley
Jun 11, 2005·Molecular Genetics and Metabolism·Tohru MaedaHajime Togari
Sep 18, 2009·Nature·David L ThomasMary Carrington
Jan 20, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fumitaka SuzukiHiromitsu Kumada
Sep 8, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marc G GhanyUNKNOWN American Association for Study of Liver Diseases
May 16, 2012·European Journal of Gastroenterology & Hepatology·Arne Nørgaard EskesenOlav Dalgard
Apr 24, 2013·The New England Journal of Medicine·Eric LawitzEdward J Gane
Aug 16, 2013·The New England Journal of Medicine·Stefan ZeuzemFederico J Mensa
Jan 23, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jacinta A HolmesUNKNOWN CHARIOT Study Group
Feb 13, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Karolina RembeckMartin Lagging
Apr 12, 2014·The New England Journal of Medicine·Stefan ZeuzemBarry Bernstein
Apr 15, 2014·The New England Journal of Medicine·Fred PoordadBarry Bernstein
May 3, 2014·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Thomas R O'BrienRaymond P Donnelly
May 6, 2014·The New England Journal of Medicine·Peter FerenciUNKNOWN PEARL-IV Study
Jul 19, 2015·Journal of Hepatology·Thomas R O'BrienLudmila Prokunina-Olsson
Aug 4, 2015·Annals of the New York Academy of Sciences·Eric LawitzEdward Gane
Dec 29, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair M YounossiMark Wymer
Mar 5, 2016·CPT: Pharmacometrics & Systems Pharmacology·L S WuD Z D'Argenio
Sep 15, 2016·Hepatology International·Chandana PapudesuShashwatee Bagchi
Sep 27, 2016·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu
Mar 23, 2017·World Journal of Hepatology·Francesca Romana PonzianiAntonio Gasbarrini

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01833533

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.